A citation-based method for searching scientific literature

Satish K Garg, Anne L Peters, John B Buse, Thomas Danne. Diabetes Technol Ther 2018
Times Cited: 43







List of co-cited articles
270 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Dulaglutide treatment results in effective glycaemic control in latent autoimmune diabetes in adults (LADA): A post-hoc analysis of the AWARD-2, -4 and -5 Trials.
Paolo Pozzilli, Richard D Leslie, Anne L Peters, Raffaella Buzzetti, Sudha S Shankar, Zvonko Milicevic, Imre Pavo, Jeremie Lebrec, Sherry Martin, Nanette C Schloot. Diabetes Obes Metab 2018
19
5

The SimpliciT1 Study: A Randomized, Double-Blind, Placebo-Controlled Phase 1b/2 Adaptive Study of TTP399, a Hepatoselective Glucokinase Activator, for Adjunctive Treatment of Type 1 Diabetes.
Klara R Klein, Jennifer L R Freeman, Imogene Dunn, Chris Dvergsten, M Sue Kirkman, John B Buse, Carmen Valcarce. Diabetes Care 2021
2
50


Role of Amylin in Type 1 and Type 2 Diabetes.
Laura Hieronymus, Stacy Griffin. Diabetes Educ 2015
23
4

Adjunct therapy for type 1 diabetes mellitus.
Harold E Lebovitz. Nat Rev Endocrinol 2010
34
2


Beyond glycaemic control: A cross-over, double-blinded, 24-week intervention with liraglutide in type 1 diabetes.
Marie-Christine Dubé, Martin D'Amours, S John Weisnagel. Diabetes Obes Metab 2018
13
7

Type 1 diabetes.
Mark A Atkinson, George S Eisenbarth, Aaron W Michels. Lancet 2014
2

Adjunctive therapy for glucose control in patients with type 1 diabetes.
Kira Harris, Cassie Boland, Lisa Meade, Dawn Battise. Diabetes Metab Syndr Obes 2018
10
10

Discovery, characterization, and clinical development of the glucagon-like peptides.
Daniel J Drucker, Joel F Habener, Jens Juul Holst. J Clin Invest 2017
118
2

Glucokinase Activators for Type 2 Diabetes: Challenges and Future Developments.
Konstantinos A Toulis, Krishnarajah Nirantharakumar, Chrysa Pourzitaki, Anthony H Barnett, Abd A Tahrani. Drugs 2020
12
8

Insulin and Glucagon: Partners for Life.
Jens Juul Holst, William Holland, Jesper Gromada, Young Lee, Roger H Unger, Hai Yan, Kyle W Sloop, Timothy J Kieffer, Nicolas Damond, Pedro L Herrera. Endocrinology 2017
38
2


Liraglutide as adjunct to insulin treatment in type 1 diabetes does not interfere with glycaemic recovery or gastric emptying rate during hypoglycaemia: A randomized, placebo-controlled, double-blind, parallel-group study.
Christian S Frandsen, Thomas F Dejgaard, Henrik U Andersen, Jens J Holst, Bolette Hartmann, Birger Thorsteinsson, Sten Madsbad. Diabetes Obes Metab 2017
14
7

Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Mansoor Husain, Andreas L Birkenfeld, Morten Donsmark, Kathleen Dungan, Freddy G Eliaschewitz, Denise R Franco, Ole K Jeppesen, Ildiko Lingvay, Ofri Mosenzon, Sue D Pedersen,[...]. N Engl J Med 2019
403
2

β Cell dysfunction exists more than 5 years before type 1 diabetes diagnosis.
Carmella Evans-Molina, Emily K Sims, Linda A DiMeglio, Heba M Ismail, Andrea K Steck, Jerry P Palmer, Jeffrey P Krischer, Susan Geyer, Ping Xu, Jay M Sosenko. JCI Insight 2018
25
4

Addition of glucagon-like peptide-1 receptor agonist therapy to insulin in C-peptide-positive patients with type 1 diabetes.
Nitesh D Kuhadiya, Ben Prohaska, Husam Ghanim, Paresh Dandona. Diabetes Obes Metab 2019
3
33

Liraglutide for treating type 1 diabetes.
Thomas Fremming Dejgaard, Christian Seerup Frandsen, Jens Juul Holst, Sten Madsbad. Expert Opin Biol Ther 2016
9
11

Adjunct therapies in treatment of type 1 diabetes.
Itivrita Goyal, Alamgir Sattar, Megan Johnson, Paresh Dandona. J Diabetes 2020
5
20

Adjuvant Pharmacotherapies to Insulin for the Treatment of Type 1 Diabetes.
Mustafa Tosur, Maria J Redondo, Sarah K Lyons. Curr Diab Rep 2018
5
20

SGLT-2 Inhibitors in Type 1 Diabetes Mellitus: A Comprehensive Review of the Literature.
Dimitrios Patoulias, Konstantinos Imprialos, Konstantinos Stavropoulos, Vasilios Athyros, Michael Doumas. Curr Clin Pharmacol 2018
8
12


Breath acetone predicts plasma ketone bodies in children with epilepsy on a ketogenic diet.
Kathy Musa-Veloso, Sergei S Likhodii, Exequiel Rarama, Stephanie Benoit, Yeou-Mei Christiana Liu, Dominic Chartrand, Rosalind Curtis, Lionel Carmant, Anne Lortie, Felix J E Comeau,[...]. Nutrition 2006
61
2

Breath acetone is a reliable indicator of ketosis in adults consuming ketogenic meals.
Kathy Musa-Veloso, Sergei S Likhodii, Stephen C Cunnane. Am J Clin Nutr 2002
93
2

Acetone metabolism during diabetic ketoacidosis.
O E Owen, V E Trapp, C L Skutches, M A Mozzoli, R D Hoeldtke, G Boden, G A Reichard. Diabetes 1982
108
2

Guiding Ketogenic Diet with Breath Acetone Sensors.
Andreas T Güntner, Julia F Kompalla, Henning Landis, S Jonathan Theodore, Bettina Geidl, Noriane A Sievi, Malcolm Kohler, Sotiris E Pratsinis, Philipp A Gerber. Sensors (Basel) 2018
24
4

The correlation between breath acetone and blood betahydroxybutyrate in individuals with type 1 diabetes.
Gus Hancock, Shrinivas Sharma, Martin Galpin, Daniel Lunn, Clare Megson, Rob Peverall, Graham Richmond, Grant A D Ritchie, Katharine R Owen. J Breath Res 2020
2
50

Blood Ketone Bodies and Breath Acetone Analysis and Their Correlations in Type 2 Diabetes Mellitus.
Valentine Saasa, Mervyn Beukes, Yolandy Lemmer, Bonex Mwakikunga. Diagnostics (Basel) 2019
16
6

Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin-pump-treated patients with type 1 diabetes: The Lira Pump trial-a randomized, double-blinded, placebo-controlled trial.
Thomas F Dejgaard, Signe Schmidt, Christian S Frandsen, Dorte Vistisen, Sten Madsbad, Henrik U Andersen, Kirsten Nørgaard. Diabetes Obes Metab 2020
7
14

Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps.
Claresa Levetan, Laura L Want, Christian Weyer, Susan A Strobel, John Crean, Yan Wang, David G Maggs, Orville G Kolterman, Manju Chandran, Sunder R Mudaliar,[...]. Diabetes Care 2003
108
2

SGLT inhibitors in management of diabetes.
Abd A Tahrani, Anthony H Barnett, Clifford J Bailey. Lancet Diabetes Endocrinol 2013
166
2

A Meal Detection Algorithm for the Artificial Pancreas: A Randomized Controlled Clinical Trial in Adolescents With Type 1 Diabetes.
Emilie Palisaitis, Anas El Fathi, Julia E von Oettingen, Ahmad Haidar, Laurent Legault. Diabetes Care 2021
2
50

Assessing treatment barriers in young adults with type 1 diabetes.
Blake M Lancaster, Beth Pfeffer, Maxine McElligott, Agnes T Ferguson, Marilyn Miller, Dustin Wallace, James T Lane. Diabetes Res Clin Pract 2010
18
5

Closed-Loop Control Without Meal Announcement in Type 1 Diabetes.
Faye M Cameron, Trang T Ly, Bruce A Buckingham, David M Maahs, Gregory P Forlenza, Carol J Levy, David Lam, Paula Clinton, Laurel H Messer, Emily Westfall,[...]. Diabetes Technol Ther 2017
35
2

The challenges of achieving postprandial glucose control using closed-loop systems in patients with type 1 diabetes.
Véronique Gingras, Nadine Taleb, Amélie Roy-Fleming, Laurent Legault, Rémi Rabasa-Lhoret. Diabetes Obes Metab 2018
39
2

Glucose outcomes of a learning-type artificial pancreas with an unannounced meal in type 1 diabetes.
Lulu Song, Changqing Liu, Wenying Yang, Jinping Zhang, Xiaomu Kong, Bo Zhang, Xiaoping Chen, Na Wang, Dong Shen, Zhaoqing Li,[...]. Comput Methods Programs Biomed 2020
3
33

Practical implementation of automated closed-loop insulin delivery: A French position statement.
N Tubiana-Rufi, P Schaepelynck, S Franc, L Chaillous, M Joubert, E Renard, Y Reznik, C Abettan, E Bismuth, J Beltrand,[...]. Diabetes Metab 2021
1
100



New closed-loop insulin systems.
Charlotte K Boughton, Roman Hovorka. Diabetologia 2021
15
6

Active sugar transport in health and disease.
E M Wright, B A Hirayama, D F Loo. J Intern Med 2007
400
2

Undertreatment of cardiovascular risk factors in the type 1 diabetes exchange clinic network (United States) and the prospective diabetes follow-up (Germany/Austria) registries.
Viral N Shah, Julia M Grimsmann, Nicole C Foster, Axel Dost, Kellee M Miller, Marianne Pavel, Ruth S Weinstock, Wolfram Karges, David M Maahs, Reinhard W Holl. Diabetes Obes Metab 2020
12
8

Effects of Sotagliflozin Combined with Intensive Insulin Therapy in Young Adults with Poorly Controlled Type 1 Diabetes: The JDRF Sotagliflozin Study.
Bruce W Bode, Eda Cengiz, R Paul Wadwa, Phillip Banks, Thomas Danne, Jake A Kushner, Darren K McGuire, Anne L Peters, Paul Strumph, Sangeeta Sawhney. Diabetes Technol Ther 2021
2
50

Impact of overweight on chronic microvascular complications in type 1 diabetic patients.
Christophe E M De Block, Ivo H De Leeuw, Luc F Van Gaal. Diabetes Care 2005
78
2

The impact of using a closed-loop system on food choices and eating practices among people with Type 1 diabetes: a qualitative study involving adults, teenagers and parents.
J Lawton, M Blackburn, D Rankin, J Allen, F Campbell, L Leelarathna, M Tauschmann, H Thabit, M E Wilinska, R Hovorka. Diabet Med 2019
13
7

Obesity is associated with retinopathy and macrovascular disease in type 1 diabetes.
Sarah A Price, Alexandra Gorelik, Spiros Fourlanos, Peter G Colman, John M Wentworth. Obes Res Clin Pract 2014
36
2

A decade of temporal trends in overweight/obesity in youth with type 1 diabetes after the Diabetes Control and Complications Trial.
Charumathi Baskaran, Lisa K Volkening, Monica Diaz, Lori M Laffel. Pediatr Diabetes 2015
33
3

Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes.
Roselle A Herring, Fariba Shojaee-Moradie, Robert Garesse, Mary Stevenage, Nicola Jackson, Barbara A Fielding, Agampodi Mendis, Sigurd Johnsen, A Margot Umpleby, Melanie Davies,[...]. Diabetes Care 2020
5
20

Assessment of Risks and Benefits of Beta Cell Replacement Versus Automated Insulin Delivery Systems for Type 1 Diabetes.
Peter Senior, Anna Lam, Kate Farnsworth, Bruce Perkins, Remi Rabasa-Lhoret. Curr Diab Rep 2020
3
33

Dual-Hormone Closed-Loop System Using a Liquid Stable Glucagon Formulation Versus Insulin-Only Closed-Loop System Compared With a Predictive Low Glucose Suspend System: An Open-Label, Outpatient, Single-Center, Crossover, Randomized Controlled Trial.
Leah M Wilson, Peter G Jacobs, Katrina L Ramsey, Navid Resalat, Ravi Reddy, Deborah Branigan, Joseph Leitschuh, Virginia Gabo, Florian Guillot, Brian Senf,[...]. Diabetes Care 2020
9
11


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.